TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
IONS

Ionis Pharmaceuticals Inc

Healthcare · Biotechnology

44.50$ +1.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Ionis Pharmaceuticals Inc (IONS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 268 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IONS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
144 119 119 225 134 227 132 452 157 203 246 268 874
2.2 2.2 2.2 4.2 1.1 3.8 1.5 4.2 2.3 8.0 3.0 2.7 16
142 117 117 221 133 223 130 448 154 195 243 265 858
215 214 214 222 220 245 201 217 218 280 210 217 925
70 53 53 65 62 88 76 91 97 130 150 150 528
285 267 267 287 281 334 277 308 315 410 361 368 1,453
-143 -150 -150 -66 -149 -111 -147 140 -160 -215 -117 -102 -595
22 22 22 23 23 23 23 23 22 23 22 22 89
-141 -143 -143 -66 -144 -107 -147 124 -128 -228 -92 -113 -562
6.6 0.1 0.1 0.1 -3.6 -2.7 0.1 0.0 0.2 1.0 0.2 -1.3 0.2
-147 -143 -143 -66 -140 -104 -147 124 -129 -229 -93 -115 -565
-115 -117 -117 -38 -117 -81 -120 150 -103 4,607 -69 -105 4,330

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?